Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says
The epidemiology of sudden cardiac deaths (SCDs) was turned on its head Thursday, with research showing that in reality, ischemic ...
FDA, CMS to Launch Speedy Coverage Pathway for Breakthrough Medical Devices
Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage at the same time under a ...
DMR Slows Post-Tirzepatide Weight Regain
Early results from a pilot study show the minimally invasive endoscopic intervention reduces the weight gain that occurs following discontinuation ...
The Most Lethal Cancers Get Shortchanged by Federal Funding, Study Shows
A study showed that cancers with higher mortality risk received less federal funding per death compared with cancers that had ...
Warning Signs in Young-Onset CRC Data; Rifaximin Drift in Cirrhosis; Neonatal Hep C
Among French patients under 40 with early-onset colorectal cancer (CRC), the incidence of multiple-site metastases increased by 10% annually from ...
UK Biobank Members’ Health Data Found for Sale on Alibaba
The UK government confirmed the breach after Biobank data on all 500,000 members appeared listed for sale, though names and ...
Health Data for 500,000 Members of a U.K. Project Offered for Sale Online in China
DNA and other confidential health data from 500,000 people who volunteered for a massive U.K. health study were offered for ...
Largest ever octopus was great white shark of invertebrate predators
A reconstruction of the giant octopusYohei Utsuki/Department of Earth and Planetary Sciences, Hokkaido University While dinosaurs ruled the land, Cretaceous ...
Lonapegsomatropin Shows Long-Term Benefit in Adult GHD
A 52-week extension study showed that the drug continues to maintain favorable body composition with no safety issues. Medscape Medical ...
One-Month Limit Imposed on Ramipril 1.25-mg Supplies
New shortage protocol allows UK pharmacists to restrict dispensing as supply pressures hit a drug used by millions. Medscape News ...
FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to ...
Do you need to worry about Mythos, Anthropic’s computer-hacking AI?
Anthropic’s Project Glasswing aims to improve online securityJonathan Raa/NurPhoto via Getty Images) The past few weeks have brought apparently alarming ...
The surprising health benefit that could be in your pint
Drinking the odd pint of beer can provide "substantial levels" of an essential brain-boosting vitamin in your diet, according to ...
Challenges of Placebo Arms in Weight-Loss Drug Trials
Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity ...
Stiff Person Syndrome Patients Regain Mobility After Single-Dose Cell Therapy
A single dose of mivocabtagene autoleucel (miv-cel), an autologous CD19 chimeric antigen receptor (CAR)-T cell therapy, showed benefit in people ...
Colorectal Cancer Predicted to Keep Rising in Younger Adults
Researchers say the rise in colorectal cancer among Americans younger than 45 is likely to keep accelerating over the next ...
Catching a cold can delay cancer from spreading to the lungs
Infecting mice with RSV, a common virus that causes cold-like symptoms, prevented breast cancer cells from reaching their lungs. This ...
Regeneron Wins FDA Approval for First Gene Therapy for Genetic Hearing Loss
The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare genetic form of deafness, the company ...
More Positive Survival Data in Lung Cancer With Perioperative Therapy
SAN DIEGO -- Patients with operable non-small cell lung cancer (NSCLC) had significantly longer event-free survival (EFS) with perioperative chemoimmunotherapy, ...
FDA Approves Pediatric Urticaria Indication for Dupilumab
The biologic is now indicated for patients younger than 12 years. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-pediatric-urticaria-indication-dupilumab-2026a1000cxw?src=rss Author : ...
